Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eyepoint Pharmaceuticals Inc (NQ: EYPT )

8.000 -0.030 (-0.37%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 575,329
Open 8.090
Bid (Size) 7.860 (1)
Ask (Size) 8.250 (1)
Prev. Close 8.030
Today's Range 7.900 - 8.430
52wk Range 2.190 - 15.63
Shares Outstanding 34,984,044
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Shares of EyePoint Pharmaceuticals Were Rising Monday
The company reported positive trial data for its lead therapy to treat two different eye conditions. 
Via The Motley Fool
Why's Going On With EyePoint Pharmaceuticals Stock Today?
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) announced interim masked safety data for its lead product candidate EYP-1901 from its ongoing Phase 2 PAVIA trial of EYP-1901 as a potential nine-month... 
Via Benzinga

Performance

YTD
+119.18%
+119.18%
1 Month
-31.33%
-31.33%
3 Month
+4.44%
+4.44%
6 Month
+180.70%
+180.70%
1 Year
+14.94%
+14.94%

More News

Read More
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Where EyePoint Pharmaceuticals Stands With Analysts
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
What 6 Analyst Ratings Have To Say About EyePoint Pharmaceuticals
Via Benzinga
5 Analysts Have This to Say About EyePoint Pharmaceuticals
Via Benzinga
EyePoint Pharmaceuticals: Q1 Earnings Insights
Via Benzinga
Why Are EyePoint Pharmaceuticals Shares Trading Higher Today
Via Benzinga
EyePoint's EYP-1901 Tipped to Transform Wet AMD Market, Analyst Predicts Potential $870M Sales by 2035
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023
Via Benzinga
Why Is Alimera Sciences (ALIM) Stock Up 21% Today?
Via InvestorPlace
EyePoint Pharma Offloads Its Commercially-Available Eye Implant For $82.5M Plus Royalties
Via Benzinga
Why EyePoint Pharmaceuticals Shares Are Shooting Higher Today
Via Benzinga
R&D Activities for Treating Dry Eye Syndrome Resulting in Promising Pipeline of Treatments
Via FinancialNewsMedia
Exposures COVID-19
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Super Micro Computer, Garrett Motion, Rackspace Technology And Other Big Stocks Moving Lower On Monday
Via Benzinga
Nasdaq Edges Higher; Procter & Gamble Posts Upbeat Earnings
Via Benzinga
EyePoint Pharmaceuticals Inc. (NASDAQ: EYPT) Near the Top of Equities by Percentage Gain on 4/21
Via Investor Brand Network
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Gold Down Over 1%; US Composite PMI Rises In April
Via Benzinga
US Stocks Mostly Lower; Nasdaq Down 50 Points
Via Benzinga
Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Eyepoint Pharmaceuticals Inc. (NASDAQ: EYPT) Leading the Way in Monday Trading Based on Percentage Gain
Via Investor Brand Network
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.